Key result
Medical therapy successfully manages TAVI prosthetic valve endocarditis in an elderly patient.
Why the study?
Patients with severe aortic stenosis treated with TAVR who develop prosthetic valve endocarditis may have atypical presentations and complex management challenges due to comorbidities and surgical ineligibility.
Case Report (n=1)
Highlights the diagnostic and management challenges of prosthetic valve endocarditis following TAVR, demonstrating successful medical management in a high-risk patient.
Answers are grounded in this paper and cite their sources.
Supports medical management of TAVI endocarditis in select elderly patients; leaves open need for comparative data before broader adoption.
Transcatheter aortic valve replacement (TAVR) can improve the symptoms and prognosis of patients with severe aortic stenosis who, due to a high expected operative risk, would not have otherwise been treated surgically. If these patients develop prosthetic valve endocarditis, their presentations may be atypical causing a delay in the diagnosis and treatment. The management is also complicated by their comorbidities, and surgical treatment may not be feasible leading to a significant morbidity and mortality. We describe a case of an 85-year-old man with TAVI prosthetic valve endocarditis successfully treated medically, discuss the challenges in the diagnosis and management of such patients, and review available literature on the incidence and outcome of the condition.
No takes yet. Share an insight, caveat, or question.
Loh et al. (2012) conducted a case report in TAVI prosthetic valve endocarditis (n=1). Medical treatment was evaluated. Medical treatment successfully managed TAVI prosthetic valve endocarditis in an 85-year-old man.
Synapse has enriched 10 related papers. Consider them for comparative context: